Search results for: 'preferred desalination for clinical trials 2030'
- Did you mean
- preferred desalination for clinical trials 2020
- preferred desalination for clinical trials 2022
- Related search terms
- forging AND Casting
- 2030 us part utilities service market
- 2030 us editing pacif service market
- 2030 us editing paint service market
- 2030 us editing postur service market
-
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
04 Mar 2026  |  Global  |  Market Research
Growth Opportunities in Conversational AI in Healthcare, Global, 2025–2030
Conversational AI and Agentic AI Across Clinical and Non-clinical Workflows are Driving Transformational Growth
Conversational AI solutions are designed to enhance communication and coordination among healthcare stakeholders. These voice and text applications automate human information gathering and communications and represent a growing opportunity for healthcare organizations to improve clinician efficiency, operational and administrative efficiency, healt...
$4,950.00 -
11 Dec 2023  |  Asia Pacific  |  Frost Radar
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Aug 2020  |  Global  |  Market Research
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new t...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
22 Apr 2025  |  North America  |  Frost Radar
Frost Radar™: Clinical Decision Support Systems in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ benchmarks the growth and innovation activity of clinical decision support system (CDSS) vendors in their effort to provide end users with evidence to take the next best action. The CDSS role is evolving from just being the source of clinical knowledge at the point of care or facilitating clinical decision-making and workflow. New...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 Jul 2024  |  Global  |  Frost Radar
Frost Radar™: Clinical-Grade Wearables, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Oct 2024  |  Global  |  Market Research
Clinical Chemistry and Immunoassay Industry, Global, 2023?2028
Integrated and Scalable Core Lab Solutions Driving Transformational Growth
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...
$4,950.00
Special Price $4,207.50 save 15 %
-
16 Jan 2024  |  Global  |  Market Research
Top 5 Growth Opportunities for Clinical Diagnostics, 2024
Enabling Precision Health Journey Through Omics, Digital Diagnostics Services, and Smart Screening Solutions
Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...
$2,450.00
Special Price $1,837.50 save 25 %
-
13 Jun 2025  |  South Asia, Middle East & North Africa  |  Economic and Databases
The UAE’s Macroeconomic Transformation, 2025–2030
Policy Thrust in Green Energy, Technology, Transportation, and Logistics Solidifying its Position as a Premier Global Investment Destination
The United Arab Emirates (UAE) is poised for robust economic expansion, with real GDP growth forecast to average 4.7% between 2025 and 2030, outpacing the 2.6% recorded between 2019 and 2024. Population growth is anticipated to stay positive, reaching 12.3 million in 2030 from 11.1 million in 2024, with the share of adult and middle-aged adult and ...
$2,450.00
Special Price $2,205.00 save 10 %